University of Luxembourg

HuMiX, the personalised Human Microbial Cross-talk model, is an in-vitro platform which represents actual conditions and processes that occur within our intestines. With HuMiX, we can analyse the complex interactions between bacteria human cells and immune responses, to identify the action of probiotics and drugs and validate their mode of action on health or disease onset. We are raising seed and series A funding to implement the screening platform and initiate our discovery pipeline building on validation in oncology and immunology.

Currently leading the HuMiX microbiome start-up initiative, I have pioneered HTS, LIMS, and imaging based genotype screening at J&J Janssen research. Developed and commercialised High Content Imaging devices as CTO at Digilab / Maia Scientific. Managed a global sales network at Trinean for genomic and proteomic QC equipment. And contributed to new laboratory platforms including development and implementation of a fully automated pathogen virology lab.